Supplementary Materials and Methods from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

Autor: Xuebin Qin, Jennifer R. Brown, Jose A. Halperin, Bertal H. Aktas, Michael Chorev, Zhihai Peng, Gongxiong Wu, Jinyan Zhang, Ting Xu, Tao You, Xiaowen Ge, Weiguo Hu

Supplementary Materials and Methods from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9119103fa4899d70183c34f4dd03e0d2
https://doi.org/10.1158/0008-5472.22390946

Supplementary Figure 4 from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

Autor: Xuebin Qin, Jennifer R. Brown, Jose A. Halperin, Bertal H. Aktas, Michael Chorev, Zhihai Peng, Gongxiong Wu, Jinyan Zhang, Ting Xu, Tao You, Xiaowen Ge, Weiguo Hu

Supplementary Figure 4 from Human CD59 Inhibitor Sensitizes Rituximab-Resistant Lymphoma Cells to Complement-Mediated Cytolysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7651fb5748c495a5d657c01d4d0a682e
https://doi.org/10.1158/0008-5472.22390958.v1

The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland

Autor: Delia Bogdanet, Michelle Toth Castillo, Helen Doheny, Louise Dervan, Miguel Angel Luque-Fernandez, Jose A. Halperin, Paula M. O’Shea, Fidelma P. Dunne

Publikováno v: Acta diabetologica.

Aim Even though most pregnancies are uneventful, occasionally complications do occur. Gestational diabetes is linked to an increased risk of adverse pregnancy outcomes. Early identification of women at risk of experiencing adverse outcomes, ideally t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15985b56c686d5a4d9398879b730d660
https://pubmed.ncbi.nlm.nih.gov/36309618

Novel Biochemical Markers of Glycemia to Predict Pregnancy Outcomes in Women With Type 1 Diabetes

Autor: Diana Tundidor, Eleanor M. Scott, Diane D. Ma, Claire L Meek, Denice S. Feig, Jose A. Halperin, Rosa Corcoy, Jennifer M. Yamamoto, Helen R. Murphy

Publikováno v: DIABETES CARE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Diabetes Care

OBJECTIVE The optimal method of monitoring glycemia in pregnant women with type 1 diabetes remains controversial. This study aimed to assess the predictive performance of HbA1c, continuous glucose monitoring (CGM) metrics, and alternative biochemical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ddef7a314f83da753a66d2d9625ff2
https://doi.org/10.2337/dc20-2360

Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review

Autor: Dearbhla Murphy, Jose A. Halperin, Catriona Reddin, Fidelma Dunne, Helen C. Doheny, Paula M O'Shea, Delia Bogdanet

Publikováno v: Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 10, Iss 1533, p 1533 (2021)

Introduction: Gestational diabetes (GDM), defined as hyperglycemia with onset or initial recognition during pregnancy, has a rising prevalence paralleling the rise in type 2 diabetes (T2DM) and obesity. GDM is associated with short-term and long-term

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e930580cea91ac94e0804a515d8eee2
http://europepmc.org/articles/PMC8038821